Document:

EXHIBIT
      B

    

    OWNERSHIP
      INTERESTS AS OF March 15, 2006

     

     

    
      	
              MEMBER

            	 	
              OUTSTANDING
                

            
	 	 	
              OWNERSHIP

            
	 	 	 
	
              James
                Gunnerson

            	 	
              15%

            
	 	 	 
	
              Connie
                Kalitta

            	 	
              10%

            
	 	 	 
	
              David
                Marande

            	 	
              11.25%

            
	 	 	 
	
              Ronald
                McCaughan

            	 	
              11.25%

            
	 	 	 
	
              George
                Kelsey

            	 	
              5.00%

            
	 	 	 
	
              David
                Adams

            	 	
              8.75%

            
	 	 	 
	
              Mark
                L. McAlpine

            	 	
              13.75%

            
	 	 	 
	
              Phillip
                Elkus Trust

            	 	
              3.0%

            
	 	 	 
	
              Michele
                DeGregorio

            	 	
              5%

            
	 	 	 
	
              Susan
                A. Moss

            	 	
              .35%

            
	 	 	 
	
              RESERVED
                OWNERSHIP

            	 	
              16.65%

            
	 	 	 
	
              TOTAL

            	 	
              100%

            

    

    

    

    So
      certified:

    

    Mark
      L.
      McAlpine

    Vice
      President, Secretary and General Counsel

    

    ______________________EXCLUSIVE
      LICENSE AND ROYALTY AGREEMENT

     

    This
      Agreement is entered into this 6th day of March, 2006, by and between Life
      Signs
      Detection Systems, Inc., its officers, directors, shareholders, members,
      predecessors, successors, parent, subsidiary and all related entities or
      entities owned in common therewith (collectively the “LSDS”), with its principal
      place of business at 9304 NE 82nd
      Ct.,
      Vancouver, WA 98662 and Noninvasive Medical Technologies LLC, its officers,
      directors, shareholders, members, predecessors and successors, parent,
      subsidiary and all related entities or entities owned in common therewith
      (collectively “NMT”), whose principal place of business, is 6412 South Arville
      Street, Las Vegas, Nevada 89118 . 

    

    RECITALS

    

    NMT
      and
      LSDS entered into Confidentiality Agreement dated September 21, 2005 whereby
      the
      parties agree to share certain confidential information pursuant to the terms
      and conditions stated therein (“Confidentiality Agreement”). 

    

    LSDS
      represents that it is the owner of certain technology which will provide
      heartbeat waveform and respiration waveform through two layers of normal wear
      clothing as more fully defined in Paragraph 2 below (the “LSDS
      Technology”).

    

    NMT
      has
      entered into a contract with the U.S. Military whereby it is developing what
      is
      known as the Marco Polo project E-Tag system in connection with its desire
      to
      attempt to utilize LSDS’s vital signs monitoring technology.

    

    NMT
      and
      LSDS entered into a License Agreement Term Sheet (“LATS”)in December of 2005
      pursuant to which the parties have facilitated a transfer of the LSDS Technology
      to NMT with the understanding that each would enter into this Agreement to
      more
      fully set forth their agreement concerning NMT’s use of the LSDS Technology.

    

    NOW,
      THEREFORE, for good and valuable consideration, the adequacy of which is hereby
      acknowledged by both parties, the parties agree as follows:

     

    1. For
      and
      in consideration of the payment of Three Hundred Thousand ($300,000) Dollars
      (“Initial Payment”) and the royalty payments specified herein by NMT to LSDS,
      LSDS hereby grants to NMT and/or its successors and assigns a perpetual license
      to use and further develop the LSDS Technology and acknowledges NMT’s full
      ownership of any derivative, related or spin-off technologies which directly
      utilize LSDS’s RF technology for vital signs monitoring (collectively the
“Derivative Technologies”). NMT’s perpetual license to use the LSDS technology
      shall remain in full force and effect and may not be canceled by LSDS or anyone
      acting on its behalf as long as NMT fulfills its obligations under this
      Agreement. The Initial Payment will be paid as follows: 

     

    
      
        
        

      

      
        1
          of
          4

        
          

        

      

      
        
        

      

    

     

    
      	a.  	
              LSDS
                will be paid Twenty Five Thousand ($25,000.00) Dollars upon NMT’s receipt
                of the signed original of this Agreement at NMT’s Las Vegas, Nevada
                office.

            

    

    

    
      	b.  	
              A
                second payment of Twenty Five Thousand ($25,000.00) Dollars will
                be paid
                to LSDS upon NMT’s receipt of the components of the LSDS Technology as
                specified in Paragraph 2 which shall occur not later than January
                10,
                2006.

            

    

    

    
      	c.  	
              NMT
                will make three (3) additional payments to LSDS of Fifty Thousand
                ($50,000.00) Dollars, one on February 15, 2006, one on March 15,
                2006 and
                one on April 15, 2006, (for a total of $150,000) so long as LSDS
                remains
                in full compliance with this Agreement.

            

    

    

    
      	d.  	
              On
                May 30, 2006, NMT will make a final payment in the amount of One
                Hundred
                Thousand Dollars ($100,000.00) to LSDS representing the balance of
                the
                Initial Payment.

            

    

    

    2.  
      If not
      already delivered to NMT pursuant to the LATS, immediately upon the execution
      of
      this agreement, LSDS will deliver to NMT one working unit plus three complete
      sets of components, including design schematics in electronic form, examples
      of
      the current “board” and prototype antenna/transducers and related miscellaneous
      components, algorithms, schematics, circuit descriptions, a bill of materials
      including suppliers, supplier contact information, ‘PCB’ layout files, and
      source code for a non-contact vital signs device and all other items necessary
      to develop the LSDS technology for the Marco Polo project. LSDS hereby consents
      to have its suppliers who are associated with the LSDS Technology engaged by
      NMT
      and agrees to take all reasonable steps to facilitate NMT’s relationship with
      those suppliers.

     

    3.  (a)
      Within 21 days of NMT’s receipt of the items specified in Paragraph 2, LSDS will
      provide at NMT’s request free of charge 16 hours of engineering support in the
      person of Mike Groh at NMT’s office in Las Vegas, Nevada to assist with the
      transfer of the LSDS technology to NMT. NMT will arrange and pay for travel
      expenses. (b) After this date and through May 30, 2006, LSDS will make
      reasonable efforts to provide itself or identify additional engineering support
      at NMT’s request. Support by LSDS will be charged at $125 per hour plus travel
      expenses to be performed at times, places and for a duration to be mutually
      agreed upon. Other engineering resources are subject to the market rates
      governing those resources. LSDS’s invoice for any additional engineering support
      will be payable at the end of each month in which the support services were
      provided. LSDS’s obligation to provide such engineering support as NMT requires
      as agreed to in this paragraph is a material condition of this
      Agreement.

    

    4.  LSDS
      acknowledges that this Agreement provides NMT a perpetual license to use the
      LSDS Technology and further acknowledges that NMT shall have exclusive ownership
      and title to all Derivative Technologies. LSDS agrees that it will not make
      any
      use of, develop, sell, transfer, pledge, encumber or create any rights or
      interests in the LSDS Technology on the part any third party without the express
      written consent of NMT. LSDS expressly agrees and acknowledges that in the
      event
      of its insolvency or bankruptcy, no title or interest in or to the LSDS
      Technology will be considered to be part of the bankruptcy estate of LSDS,
      such
      having been fully conveyed and transferred to NMT by this Agreement in the
      event
      of LSDS’s insolvency or bankruptcy. 

     

    
      
        
        

      

      
        2
          of
          4

        
          

        

      

      
        
        

      

    

     

    5.  In
      addition to use with the Marco Polo project, NMT will attempt to commercialize
      the Derivative Technologies to the fullest commercially reasonable extent in
      both military and civilian markets. In further consideration for this Agreement,
      LSDS will be identified as a co-inventor of any Derivative Technologies
      developed by NMT which directly utilize the LSDS Technology, provided, however,
      that NMT shall exclusively own title and all rights to such Derivative Products.
      LSDS will receive a royalty of 5% of the actually paid gross sales of any
      Derivative Products that incorporate LSDS’s RF technology for vital signs
      monitoring which are based on LSDS’s hardware, software, technology, trade
      secrets and intellectual property conveyed in Paragraph 2, from commercial
      sales
      (“Commercial Royalty”). The Commercial Royalty will be payable annually on June
      30 based on actual receipts during the 12 months prior to the royalty payment
      and the amount of the Commercial Royalty payment shall in no event exceed 50%
      of
      the actual net profits on annual commercial sales. LSDS will also receive a
      royalty of 5% of the actually paid annual gross sales of the E/Tag device as
      defined above in connection with sales to the military/government, not to exceed
      50% of the actual net annual profits defined as actual sales as defined above,
      minus manufacturing costs, shipping and handling, 7% of the gross for service
      and 10% of the gross for G &A (“Military Royalty”). The Military Royalty
      will also be payable annually on June 30 based on gross sales and net profits
      aggregated over the 12 months prior to the royalty payment. All royalty payments
      shall be payable at the address in the first paragraph of this agreement. LSDS
      shall have the right to examine all relevant NMT financial records upon 30
      day’s
      written notice to NMT of its intent to do so for the purpose of auditing and
      verifying the royalties due and payable. NMT shall provide LSDS a statement
      of
      the calculation of the Commercial Royalty and the Military Royalty on May 15
      of
      each year specifying the number of units sold, and gross sales revenue and
      total
      profits in the case of Commercial Royalties and the calculation of actual
      received annual gross sales, manufacturing costs, shipping and handling costs,
      gross service and G&A costs for Military Royalties. LSDS acknowledges that
      these statements are to be considered confidential within the meaning of the
      Non-Disclosure Agreement referred to in the first paragraph under the heading
      “Recitals.”

    

    6.  Nothing
      in this Agreement shall be deemed to create any obligations or relationships
      between the parties which are not expressly stated herein. Neither party shall
      be considered the agent or co-venturer of the other and neither shall represent
      to any third party that such relationships exist. NMT shall have no obligation
      to enter into any other agreement with LSDS nor shall it have any liability
      whatsoever if it fails to produce civilian or military sales through the use
      of
      the LSDS Technology pursuant to this Agreement. NMT has no obligation to utilize
      the LSDS Technology in connection with the development of any products or other
      technologies.

     

    
      
        
        

      

      
        3
          of
          4

        
          

        

      

      
        
        

      

    

     

    7.  Both
      parties acknowledge and agree that the terms and requirements of the
      Confidentiality Agreement shall remain in full force and effect as though fully
      incorporated into this Agreement and that such shall remain in force for the
      life of this Agreement. 

    

    8.  No
      waiver
      or modification of this Agreement or any of its terms shall be valid or
      enforceable unless it has been reduced to writing and been signed by the party
      against whom such waiver or modification is asserted. Neither Party shall assign
      or otherwise transfer any rights conferred upon it by this Agreement without
      the
      prior written consent of the other Party. Any such attempt to assign or transfer
      by such Party without consent shall be null and void, provided, however, that
      NMT may assign this Agreement or its rights under it to a related or affiliated
      entity in connection with any sale of all or part of the assets of NMT or in
      connection with a securities offering. This agreement shall be binding on LSDS
      and NMT and their respective successors and assigns without
      limitation.

    

    9.  This
      Agreement contains the full and complete understanding of the Parties with
      respect to the subject matter of this Agreement and supersedes all prior
      representations, agreements and understandings whether oral or written. This
      Agreement shall be governed by and enforced according to the laws of the State
      of Michigan, U.S.A and both parties consent to jurisdiction and venue in the
      Circuit Court for the County of Oakland, Michigan

    

    Accepted
      and agreed:

    

    Life
      Signs Detection Systems, Inc. (LSDS) Noninvasive
      Medical Technologies LLC   

    
      	 	 
	
              /s/
                Evan Dudik

            	
              /s/
                Ronald McCaughan

            
	
              
                

                By:
                  Evan Dudik

              

            	
              
                

                By:
                  Ronald McCaughan, Ph.D.

              

            
	
              Title:
                President

            	
              Title:
                President

            
	 	 
	
              Date:
                March 8, 2006

            	
              Date:
                March 9, 2006

            

    

     

    

    
      
        
        

      

      
        4
          of
          4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00117-of-00352.parquet"}]]